Vaxcyte News

BofA Securities Maintains Vaxcyte(PCVX.US) With Buy Rating

Moomoo NewsNov 6 10:31 ET

TD Cowen Maintains Vaxcyte(PCVX.US) With Buy Rating, Maintains Target Price $135

Moomoo NewsNov 6 08:37 ET

BTIG Maintains Vaxcyte(PCVX.US) With Buy Rating, Maintains Target Price $160

Moomoo NewsNov 6 07:31 ET

Needham Maintains Vaxcyte(PCVX.US) With Buy Rating, Maintains Target Price $140

Moomoo NewsNov 6 06:33 ET

TD Cowen Maintains Vaxcyte(PCVX.US) With Buy Rating, Announces Target Price $135

Moomoo NewsNov 5 20:32 ET

Vaxcyte's Promising Clinical Advances and Strategic Plans Drive Buy Rating With $135 Price Target

TipRanksNov 5 20:07 ET

Mizuho Securities Maintains Vaxcyte(PCVX.US) With Buy Rating

Moomoo NewsOct 30 09:42 ET

TD Cowen Maintains Vaxcyte(PCVX.US) With Buy Rating

Moomoo NewsOct 24 08:34 ET

TD Cowen Maintains Vaxcyte(PCVX.US) With Buy Rating

Moomoo NewsOct 10 07:31 ET

Vaxcyte Analyst Ratings

BenzingaSep 10 09:44 ET

Mizuho Securities Maintains Vaxcyte(PCVX.US) With Buy Rating

Moomoo NewsSep 10 07:33 ET

TD Cowen Maintains Vaxcyte(PCVX.US) With Buy Rating

Moomoo NewsSep 5 07:35 ET

Guggenheim Maintains Vaxcyte(PCVX.US) With Buy Rating, Raises Target Price to $130

Moomoo NewsSep 4 09:31 ET

A Quick Look at Today's Ratings for Vaxcyte(PCVX.US), With a Forecast Between $113 to $160

Moomoo NewsSep 4 09:00 ET

Vaxcyte Is Maintained at Buy by B of A Securities

Dow JonesSep 4 07:44 ET

Vaxcyte's VAX-31 Vaccine Poised to Dominate PCV Market: A Comprehensive Buy Rating Analysis

TipRanksSep 4 05:44 ET

Vaxcyte Analyst Ratings

BenzingaSep 4 00:59 ET

Vaxcyte's V AX-31 Demonstrates Market Disruption Potential With Strong Clinical Trial Results; Buy Rating Reaffirmed With Increased Price Target

TipRanksSep 3 12:07 ET

Buy Rating Affirmed for Vaxcyte Ahead of Key VAX-31 Phase 1/2 Milestone

TipRanksAug 7 05:47 ET

Vaxcyte Analyst Ratings

BenzingaAug 7 05:43 ET